About Us
Business Model
Enaltec Labs has evolved a region based business strategy based on its core competence technology.
Regulated Markets
To develop niche small volume APIs
Focus on small volume APIs, which could be of no commercial interest for large API manufacturing companies as their plant scale will not make it economically feasible to manufacture such small volume products at competitive price like Nepafenac, Bromefenac etc.
Develop APIs where there are no active DMFs operating in US or EU.
To develop specific technology based APIs, like prostaglandins etc.
To develop products close to approval dates of brands, so that Enaltec would be the lone supplier initially to work at R&D stage with generic companies fairly early so that the relationship is locked. This will also enable Enaltec to be a new product premium supplier and better relationships with generic companies.
To develop IP strategy for molecules which are yet to be approved and file process patents, polymorph/salt patents encompassing the product which would provide a unique platform for the company to partner with generic companies.
Patent Protected Markets And Plant Inspection Markets (Other Than US & EU)
Countries included in this category are: Mexico, Turkey, S.Korea, Brazil Argentina, China, Iran etc.
Since such markets require cost competitiveness and price advantage available here are not as huge as regulated markets.
For various integrated companies these markets are more attractive on launching generic formulations as these markets also have faster registration process.
Enaltec has developed successfully and filed various process patents in some of these markets.
Enaltec has dedicated plant with focus on these markets complying to the regulatory requirements of these countries, and which supports cost effective way for production of products with focus..
Less Regulated Markets
Markets like India, Syria, Egypt, Pakistan, Bangladesh etc.
Enaltec's strategy for these markets is:
New products - which are first time in these countries (not yet off patent in regulated markets). Generic companies in such markets are continuously looking for new products launched and approved in regulated markets.
Develop cost competitive products - Products which are already existing in markets with few restricted manufacturers; Enaltec with its chemistry capabilities would pick up such products work on cost competitiveness and tie up with generic companies to offer such products.
Copyright © Enaltec Labs Pvt. Ltd. 2009. All Rights Reserved.
